因美纳致力于推动表观遗传学及其在细胞健康、发育、调控、疾病等方面作用的前沿发展。我们很荣幸能参与这一新兴的、令人兴奋的领域,为影响健康和疾病的发现提供工具。
符合条件的申请人将受邀提交新项目的摘要(最多400字),介绍Infinium Methylation Screening Array-48 Kit的使用情况,该奖项的价值超过100,000美元。
2025 Illumina 表观遗传学研究资助计划现已开放申请。所有申请材料须在 2025 年 8 月 24 日太平洋时间 23:59 前提交。
评审委员会将从所有合格申请中遴选一名获奖者,评审将依据以下标准:
获奖者将获得 1008 份 Infinium Methylation Screening Array-48 Kit(奖品)。
点击申请该资助计划向学术、营利或非营利机构的基因组学基础研究人员开放。
申请者需提交400字以内的书面摘要,包含研究概述、工作陈述,以及研究将产生的影响。摘要最多可包含3张图(带图例)和1个引用列表(200字以内)。
摘要应包含以下内容:
为确保您提交资料的有效性,所有报名材料必须:
Publication of Project Results:
All grant submissions are confidential to the individual submitter and will not be published or distributed, provided, however, Illumina may share them with their own staff and distributors, who will not disclose them to third parties. Illumina may support the grant advertising efforts.
The winner will be selected by a panel of judges selected by Illumina. The panel may include representatives from Illumina. Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by Illumina and the winner: webinar, case study, blog post, poster presentation, or conference presentation. The winner agrees that Illumina shall have the right to publicly announce the winner’s name and research title and use anonymized data from the winner's projects in application notes including in marketing materials and seminars- no public display of data will happen without prior consent from the winner.
Eligibility and Requirements:
By submitting a grant application, each applicant agrees that Illumina may use his or her name, abstract title, for marketing purposes.
All grant applicants agree that Illumina may process the personal data he or she provides as part of application, including sharing such data with Illumina’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with Illumina’s privacy policies.
Applicants agree that Illumina may use applicant’s names, email addresses and affiliated institution to contact applicants for purposes of marketing of its products and services in accordance with the Illumina privacy policy here.
The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by Illumina. No substitution or transfer of the awarded prize is allowed except as permitted by Illumina. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of Illumina, then Illumina reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. These terms and conditions and any action related to this grant program will be governed by the laws of the State of California without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in San Diego County, California, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.
下载这份 Infinium 甲基化芯片与表观遗传研究指南,获取关于研究设计与实施的洞见,深入理解人类健康和疾病中的表观遗传机制。
了解表观基因组学与表观遗传学,探索 DNA 甲基化、DNA-蛋白相互作用、染色质可及性、组蛋白修饰等研究方向及解决方案。
了解利用新一代测序(NGS)等高通量技术进行DNA甲基化分析的更多信息。